What follows is a stock analysis showing a specific look at how Spectrum Pharmaceuticals Inc (SPPI) fares in the ModernGraham valuation …
Spectrum Pharmaceuticals
It was a rough third quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during the quarter. The Russell 2000, composed of smaller …
Science and Public Policy Institute
The main US indexes rallied on Friday, with all three benchmarks closing at record highs for a second straight …
Donald Trump
Spectrum Pharmaceuticals (NASDAQ:SPPI) traded down 2.15% during trading on Wednesday, hitting $4.55. 129,790 shares of the stock traded hands. The company has a 50-day moving average price of $4.38 and a …
Middle East
SPPI) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 21,553 shares of the biotechnology company’s stock, valued at approximately $101,000. A number of other …
Science and Public Policy Institute
One stock that might be an intriguing choice for investors right now is Spectrum Pharmaceuticals, Inc. ( SPPI). This is because this security in the Medicine- Drugs space is seeing solid earnings estimate revision activity, …
SPPI) by 90.9% during the third quarter, Holdings Channel reports. The firm owned 189,374 shares of the biotechnology company’s stock after buying an additional 90,164 shares during the period. BlackRock …
BlackRock
While the FDA can still vote to approve the drug in its final ruling in mid-December, SPPI stock is down 5.3% this afternoon at $5.20, after earlier being halted for volatility. This negative price action is nothing new for SPPI, …
Luna Emery is a financial writer. She graduated with a degree in Economics. She has contributed to major financial websites and print publications for over 8 years. She handles much of this site's news coverage for …